BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Christensen KD, Dukhovny D, Siebert U, Green RC. Assessing the Costs and Cost-Effectiveness of Genomic Sequencing. J Pers Med 2015;5:470-86. [PMID: 26690481 DOI: 10.3390/jpm5040470] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 8.1] [Reference Citation Analysis]
Number Citing Articles
1 Pagès A, Foulon S, Zou Z, Lacroix L, Lemare F, de Baère T, Massard C, Soria J, Bonastre J. The cost of molecular-guided therapy in oncology: a prospective cost study alongside the MOSCATO trial. Genet Med 2017;19:683-90. [DOI: 10.1038/gim.2016.174] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
2 Grubb AL, McDonald TJ, Rutters F, Donnelly LA, Hattersley AT, Oram RA, Palmer CNA, van der Heijden AA, Carr F, Elders PJM, Weedon MN, Slieker RC, 't Hart LM, Pearson ER, Shields BM, Jones AG. A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody-Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy. Diabetes Care 2019;42:208-14. [PMID: 30352895 DOI: 10.2337/dc18-0431] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
3 Presley CJ, Tang D, Soulos PR, Chiang AC, Longtine JA, Adelson KB, Herbst RS, Zhu W, Nussbaum NC, Sorg RA, Agarwala V, Abernethy AP, Gross CP. Association of Broad-Based Genomic Sequencing With Survival Among Patients With Advanced Non-Small Cell Lung Cancer in the Community Oncology Setting. JAMA 2018;320:469-77. [PMID: 30088010 DOI: 10.1001/jama.2018.9824] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 18.0] [Reference Citation Analysis]
4 van Amerongen RA, Retèl VP, Coupé VM, Nederlof PM, Vogel MJ, van Harten WH. Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis. Ecancermedicalscience 2016;10:684. [PMID: 27899957 DOI: 10.3332/ecancer.2016.684] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
5 Dunn P, Albury CL, Maksemous N, Benton MC, Sutherland HG, Smith RA, Haupt LM, Griffiths LR. Next Generation Sequencing Methods for Diagnosis of Epilepsy Syndromes. Front Genet 2018;9:20. [PMID: 29467791 DOI: 10.3389/fgene.2018.00020] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 10.8] [Reference Citation Analysis]
6 Tegally H, San JE, Giandhari J, de Oliveira T. Unlocking the efficiency of genomics laboratories with robotic liquid-handling. BMC Genomics 2020;21:729. [PMID: 33081689 DOI: 10.1186/s12864-020-07137-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Vaiman D. Genetic and Epigenetic Marks Weave Intricate Connections in Cardiac Disease. Circ Res 2016;118:773-5. [PMID: 26941418 DOI: 10.1161/CIRCRESAHA.116.308339] [Reference Citation Analysis]
8 Schoenberger SP. Is It Possible to Develop Cancer Vaccines to Neoantigens, What Are the Major Challenges, and How Can These Be Overcome? Targeting the Right Antigens in the Right Patients. Cold Spring Harb Perspect Biol 2018;10:a028837. [PMID: 29254974 DOI: 10.1101/cshperspect.a028837] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
9 Parker Z, Maslamoney S, Meintjes A, Botha G, Panji S, Hazelhurst S, Mulder N. Building Infrastructure for African Human Genomic Data Management. Data Science Journal 2019;18:47. [DOI: 10.5334/dsj-2019-047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Granger MJ, Eck PK, Vazquez-Vidal I, Shamloo M, House JD, Mackay DS. Genosets for APOE and CYP7A1-rs3808607 variants do not predict low-density lipoprotein cholesterol lowering upon intervention with plant sterols in a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2021:nqab378. [PMID: 34791009 DOI: 10.1093/ajcn/nqab378] [Reference Citation Analysis]
11 Wang MH, Weng H. Genetic Test, Risk Prediction, and Counseling. In: Shen B, editor. Translational Informatics in Smart Healthcare. Singapore: Springer; 2017. pp. 21-46. [DOI: 10.1007/978-981-10-5717-5_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
12 Raskin L, Guo Y, Du L, Clendenning M, Rosty C, Lindor NM, Gruber SB, Buchanan DD; Colon Cancer Family Registry (CCFR). Targeted sequencing of established and candidate colorectal cancer genes in the Colon Cancer Family Registry Cohort. Oncotarget 2017;8:93450-63. [PMID: 29212164 DOI: 10.18632/oncotarget.18596] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
13 Adam S, Friedman JM. Controversy and debate on clinical genomics sequencing-paper 4: clinical genome-wide sequencing: response to Wilson, Miller, and Rousseau. J Clin Epidemiol 2017;92:13-5. [PMID: 28951108 DOI: 10.1016/j.jclinepi.2017.09.019] [Reference Citation Analysis]
14 Lee HH, Lau WL, Ko CH, Lee KC, Cheng FY, Wong S, Woo YH, Mak CM. Flexi-Myo Panel Strategy: Genomic Diagnoses of Myopathies and Muscular Dystrophies by Next-Generation Sequencing. Genet Test Mol Biomarkers 2020;24:99-104. [PMID: 30907627 DOI: 10.1089/gtmb.2018.0185] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
15 Chen J. A fully-automated event-based variant prioritizing solution to the CAGI5 intellectual disability gene panel challenge. Hum Mutat 2019;40:1364-72. [PMID: 31066479 DOI: 10.1002/humu.23781] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
16 Loubière S, Drezet A, Beau-faller M, Moro-sibilot D, Friard S, Wislez M, Blons H, Daniel C, Westeel V, Madroszyk A, Léna H, Merle P, Mazières J, Zalcman G, Lacave R, Antoine M, Morin F, Missy P, Barlesi F, Auquier P, Cadranel J. Cost-effectiveness of KRAS , EGFR and ALK testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study. Eur Respir J 2018;51:1701467. [DOI: 10.1183/13993003.01467-2017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
17 Jose R, Rooney R, Nagisetty N, Davis R, Hains D. Biorepository and integrative genomics initiative: designing and implementing a preliminary platform for predictive, preventive and personalized medicine at a pediatric hospital in a historically disadvantaged community in the USA. EPMA J 2018;9:225-34. [PMID: 30174759 DOI: 10.1007/s13167-018-0141-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Dragojlovic N, Kim E, Elliott AM, Friedman JM, Lynd LD; CAUSES Study. Evaluating the use of parental reports to estimate health care resource utilization in children with suspected genetic disorders. J Eval Clin Pract 2018;24:416-22. [DOI: 10.1111/jep.12876] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
19 Green RC, Goddard KAB, Jarvik GP, Amendola LM, Appelbaum PS, Berg JS, Bernhardt BA, Biesecker LG, Biswas S, Blout CL, Bowling KM, Brothers KB, Burke W, Caga-Anan CF, Chinnaiyan AM, Chung WK, Clayton EW, Cooper GM, East K, Evans JP, Fullerton SM, Garraway LA, Garrett JR, Gray SW, Henderson GE, Hindorff LA, Holm IA, Lewis MH, Hutter CM, Janne PA, Joffe S, Kaufman D, Knoppers BM, Koenig BA, Krantz ID, Manolio TA, McCullough L, McEwen J, McGuire A, Muzny D, Myers RM, Nickerson DA, Ou J, Parsons DW, Petersen GM, Plon SE, Rehm HL, Roberts JS, Robinson D, Salama JS, Scollon S, Sharp RR, Shirts B, Spinner NB, Tabor HK, Tarczy-Hornoch P, Veenstra DL, Wagle N, Weck K, Wilfond BS, Wilhelmsen K, Wolf SM, Wynn J, Yu JH; CSER Consortium. Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine. Am J Hum Genet 2016;98:1051-66. [PMID: 27181682 DOI: 10.1016/j.ajhg.2016.04.011] [Cited by in Crossref: 92] [Cited by in F6Publishing: 86] [Article Influence: 15.3] [Reference Citation Analysis]
20 Smith HS, McGuire AL, Wittenberg E, Lavelle TA. Family-level impact of genetic testing: integrating health economics and ethical, legal, and social implications. Per Med 2021;18:209-12. [PMID: 33728981 DOI: 10.2217/pme-2021-0016] [Reference Citation Analysis]
21 Krier JB, Kalia SS, Green RC. Genomic sequencing in clinical practice: applications, challenges, and opportunities. Dialogues Clin Neurosci 2016;18:299-312. [PMID: 27757064 [PMID: 27757064 DOI: 10.31887/dcns.2016.18.3/jkrier] [Cited by in Crossref: 33] [Article Influence: 6.6] [Reference Citation Analysis]
22 [DOI: 10.1101/203554] [Cited by in Crossref: 41] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
23 Délot EC, Papp JC, Sandberg DE, Vilain E; DSD-TRN Genetics Workgroup. Genetics of Disorders of Sex Development: The DSD-TRN Experience. Endocrinol Metab Clin North Am 2017;46:519-37. [PMID: 28476235 DOI: 10.1016/j.ecl.2017.01.015] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
24 Johnson KB, Clayton EW, Starren J, Peterson J. The Implementation Chasm Hindering Genome-informed Health Care. J Law Med Ethics 2020;48:119-25. [PMID: 32342791 DOI: 10.1177/1073110520916999] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
25 Cragun D, Kinney AY, Pal T. Care delivery considerations for widespread and equitable implementation of inherited cancer predisposition testing. Expert Rev Mol Diagn 2017;17:57-70. [PMID: 27910721 DOI: 10.1080/14737159.2017.1267567] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
26 Stuttgen K, Pacyna J, Beck A, Kullo IJ, Sharp RR. Patient reactions to receiving negative genomic screening results by mail. Genet Med 2020;22:1994-2002. [PMID: 32669678 DOI: 10.1038/s41436-020-0906-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Christensen KD, Phillips KA, Green RC, Dukhovny D. Cost Analyses of Genomic Sequencing: Lessons Learned from the MedSeq Project. Value Health 2018;21:1054-61. [PMID: 30224109 DOI: 10.1016/j.jval.2018.06.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
28 Gibson KM, Nesbitt A, Cao K, Yu Z, Denenberg E, Dechene E, Guan Q, Bhoj E, Zhou X, Zhang B, Wu C, Dubbs H, Wilkens A, Medne L, Bedoukian E, White PS, Pennington J, Lou M, Conlin L, Monos D, Sarmady M, Marsh E, Zackai E, Spinner N, Krantz I, Deardorff M, Santani A. Novel findings with reassessment of exome data: implications for validation testing and interpretation of genomic data. Genet Med 2018;20:329-36. [DOI: 10.1038/gim.2017.153] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
29 Schilit SL, Schilit Nitenson A. My Identical Twin Sequenced our Genome. J Genet Couns 2017;26:276-8. [PMID: 27853911 DOI: 10.1007/s10897-016-0046-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Alam K, Schofield D. Economic evaluation of genomic sequencing in the paediatric population: a critical review. Eur J Hum Genet 2018;26:1241-7. [PMID: 29795475 DOI: 10.1038/s41431-018-0175-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
31 Meyer D, Fu BXH, Chavez M, Loeillet S, Cerqueira PG, Nicolas A, Heyer WD. Cooperation between non-essential DNA polymerases contributes to genome stability in Saccharomyces cerevisiae. DNA Repair (Amst) 2019;76:40-9. [PMID: 30818168 DOI: 10.1016/j.dnarep.2019.02.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
32 Arora NS, Davis JK, Kirby C, McGuire AL, Green RC, Blumenthal-Barby JS, Ubel PA; MedSeq Project. Communication challenges for nongeneticist physicians relaying clinical genomic results. Per Med 2016;14:423-31. [PMID: 29181085 DOI: 10.2217/pme-2017-0008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
33 Liu C, Peng P, Li W, Ye C, Zhang S, Wang R, Li D, Guan S, Zhang L, Huang X, Guo Z, Guo J, Long Y, Li L, Pan G, Tian B, Xiao J. Deciphering variation of 239 elite japonica rice genomes for whole genome sequences-enabled breeding. Genomics 2021;113:3083-91. [PMID: 34237377 DOI: 10.1016/j.ygeno.2021.07.002] [Reference Citation Analysis]
34 Zoltick ES, Linderman MD, McGinniss MA, Ramos E, Ball MP, Church GM, Leonard DGB, Pereira S, McGuire AL, Caskey CT, Sanderson SC, Schadt EE, Nielsen DE, Crawford SD, Green RC; PeopleSeq Consortium. Predispositional genome sequencing in healthy adults: design, participant characteristics, and early outcomes of the PeopleSeq Consortium. Genome Med 2019;11:10. [PMID: 30808425 DOI: 10.1186/s13073-019-0619-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 7.3] [Reference Citation Analysis]
35 Lee HH, Lau NK, Yeung CW, Ng SG, Yau KE, Mak CM. Successful Adaptation of Targeted Gene Panel Next-Generation Sequencing in Regional Hospital in Hong Kong: Genomic Diagnosis of SCN2A-Related Seizure Disorder. Chin Med J (Engl) 2018;131:2262-4. [PMID: 30203812 DOI: 10.4103/0366-6999.240812] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Joshi E, Mighton C, Clausen M, Casalino S, Kim THM, Kowal C, Birken C, Maguire JL, Bombard Y. Primary care provider perspectives on using genomic sequencing in the care of healthy children. Eur J Hum Genet 2020;28:551-7. [PMID: 31804631 DOI: 10.1038/s41431-019-0547-6] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Hayeems RZ, Bhawra J, Tsiplova K, Meyn MS, Monfared N, Bowdin S, Stavropoulos DJ, Marshall CR, Basran R, Shuman C, Ito S, Cohn I, Hum C, Girdea M, Brudno M, Cohn RD, Scherer SW, Ungar WJ. Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray. Eur J Hum Genet 2017;25:1303-12. [PMID: 29158552 DOI: 10.1038/s41431-017-0020-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
38 Bean LJH, Scheuner MT, Murray MF, Biesecker LG, Green RC, Monaghan KG, Palomaki GE, Sharp RR, Trotter TL, Watson MS, Powell CM; ACMG Board of Directors. DNA-based screening and personal health: a points to consider statement for individuals and health-care providers from the American College of Medical Genetics and Genomics (ACMG). Genet Med 2021;23:979-88. [PMID: 33790423 DOI: 10.1038/s41436-020-01083-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Cirino AL, Lakdawala NK, McDonough B, Conner L, Adler D, Weinfeld M, O'Gara P, Rehm HL, Machini K, Lebo M, Blout C, Green RC, MacRae CA, Seidman CE, Ho CY; MedSeq Project*. A Comparison of Whole Genome Sequencing to Multigene Panel Testing in Hypertrophic Cardiomyopathy Patients. Circ Cardiovasc Genet 2017;10:e001768. [PMID: 29030401 DOI: 10.1161/CIRCGENETICS.117.001768] [Reference Citation Analysis]
40 Ontiveros ES, Ueda Y, Harris SP, Stern JA; 99 Lives Consortium. Precision medicine validation: identifying the MYBPC3 A31P variant with whole-genome sequencing in two Maine Coon cats with hypertrophic cardiomyopathy. J Feline Med Surg 2019;21:1086-93. [PMID: 30558461 DOI: 10.1177/1098612X18816460] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
41 Hayeems RZ, Dimmock D, Bick D, Belmont JW, Green RC, Lanpher B, Jobanputra V, Mendoza R, Kulkarni S, Grove ME, Taylor SL, Ashley E; Medical Genome Initiative. Clinical utility of genomic sequencing: a measurement toolkit. NPJ Genom Med 2020;5:56. [PMID: 33319814 DOI: 10.1038/s41525-020-00164-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
42 Harris E, Topf A, Barresi R, Hudson J, Powell H, Tellez J, Hicks D, Porter A, Bertoli M, Evangelista T, Marini-Betollo C, Magnússon Ó, Lek M, MacArthur D, Bushby K, Lochmüller H, Straub V. Exome sequences versus sequential gene testing in the UK highly specialised Service for Limb Girdle Muscular Dystrophy. Orphanet J Rare Dis 2017;12:151. [PMID: 28877744 DOI: 10.1186/s13023-017-0699-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 4.6] [Reference Citation Analysis]
43 Birch P, Adam S, Bansback N, Coe RR, Hicklin J, Lehman A, Li KC, Friedman JM. DECIDE: a Decision Support Tool to Facilitate Parents’ Choices Regarding Genome-Wide Sequencing. J Genet Counsel 2016;25:1298-308. [DOI: 10.1007/s10897-016-9971-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
44 Uveges MK, Holm IA. Current Trends in Genetics and Neonatal Care. Adv Neonatal Care 2021;21:473-81. [PMID: 33538495 DOI: 10.1097/ANC.0000000000000834] [Reference Citation Analysis]
45 Etchegary H, Wilson B, Rahman P, Simmonds C, Pullman D. Public interest in whole genome sequencing and information needs: an online survey study. Personalized Medicine 2020;17:283-93. [DOI: 10.2217/pme-2019-0136] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
46 Vu M, Degeling K, Martyn M, Lynch E, Chong B, Gaff C, IJzerman MJ. Evaluating the resource implications of different service delivery models for offering additional genomic findings. Genet Med 2021;23:606-13. [PMID: 33214711 DOI: 10.1038/s41436-020-01030-8] [Reference Citation Analysis]
47 Fontes Marx M, Ataguba JE, de Vries J, Wonkam A. Systematic Review of the Economic Evaluation of Returning Incidental Findings in Genomic Research. Front Public Health 2021;9:697381. [PMID: 34277554 DOI: 10.3389/fpubh.2021.697381] [Reference Citation Analysis]
48 Cirino AL, Lakdawala NK, McDonough B, Conner L, Adler D, Weinfeld M, O'Gara P, Rehm HL, Machini K, Lebo M, Blout C, Green RC, MacRae CA, Seidman CE, Ho CY; MedSeq Project*. A Comparison of Whole Genome Sequencing to Multigene Panel Testing in Hypertrophic Cardiomyopathy Patients. Circ Cardiovasc Genet 2017;10:e001768. [PMID: 29030401 DOI: 10.1161/CIRCGENETICS.117.001768] [Cited by in Crossref: 38] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
49 Phillips KA, Deverka PA, Marshall DA, Wordsworth S, Regier DA, Christensen KD, Buchanan J. Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions. Value Health 2018;21:1033-42. [PMID: 30224106 DOI: 10.1016/j.jval.2018.06.017] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
50 Linderman MD, Nielsen DE, Green RC. Personal Genome Sequencing in Ostensibly Healthy Individuals and the PeopleSeq Consortium. J Pers Med 2016;6:E14. [PMID: 27023617 DOI: 10.3390/jpm6020014] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
51 Wang S, Qian F, Zheng Y, Ogundiran T, Ojengbede O, Zheng W, Blot W, Nathanson KL, Hennis A, Nemesure B, Ambs S, Olopade OI, Huo D. Genetic variants demonstrating flip-flop phenomenon and breast cancer risk prediction among women of African ancestry. Breast Cancer Res Treat 2018;168:703-12. [PMID: 29302764 DOI: 10.1007/s10549-017-4638-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
52 Weiss ST. Implementing Personalized Medicine in the Academic Health Center. J Pers Med 2016;6:E18. [PMID: 27657137 DOI: 10.3390/jpm6030018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
53 Marino P, Touzani R, Perrier L, Rouleau E, Kossi DS, Zhaomin Z, Charrier N, Goardon N, Preudhomme C, Durand-Zaleski I, Borget I, Baffert S; NGSEco Group:. Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study. Eur J Hum Genet 2018;26:314-23. [PMID: 29367707 DOI: 10.1038/s41431-017-0081-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 8.5] [Reference Citation Analysis]
54 Van Bel M, Diels T, Vancaester E, Kreft L, Botzki A, Van de Peer Y, Coppens F, Vandepoele K. PLAZA 4.0: an integrative resource for functional, evolutionary and comparative plant genomics. Nucleic Acids Res 2018;46:D1190-6. [PMID: 29069403 DOI: 10.1093/nar/gkx1002] [Cited by in Crossref: 209] [Cited by in F6Publishing: 167] [Article Influence: 69.7] [Reference Citation Analysis]
55 Fodor A, Karnieli E. Challenges of implementing personalized (precision) medicine: a focus on diabetes. Personalized Medicine 2016;13:485-97. [DOI: 10.2217/pme-2016-0022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
56 Adu-Oppong B, Gasparrini AJ, Dantas G. Genomic and functional techniques to mine the microbiome for novel antimicrobials and antimicrobial resistance genes. Ann N Y Acad Sci 2017;1388:42-58. [PMID: 27768825 DOI: 10.1111/nyas.13257] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
57 Alon I, Guimón J, Urbanos-garrido R. What to expect from assisted reproductive technologies? Experts' forecasts for the next two decades. Technological Forecasting and Social Change 2019;148:119722. [DOI: 10.1016/j.techfore.2019.119722] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
58 Sebate B, Cuttler K, Cloete R, Britz M, Christoffels A, Williams M, Carr J, Bardien S. Prioritization of candidate genes for a South African family with Parkinson's disease using in-silico tools. PLoS One 2021;16:e0249324. [PMID: 33770142 DOI: 10.1371/journal.pone.0249324] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Hull LE, Vassy JL. Toward greater understanding of patient decision-making around genome sequencing. Per Med 2018;15:57-66. [PMID: 29714114 DOI: 10.2217/pme-2017-0037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]